Latest Insider Transactions at Casi Pharmaceuticals, Inc. (CASI)
This section provides a real-time view of insider transactions for Casi Pharmaceuticals, Inc. (CASI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CASI Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CASI Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
33,300
+8.23%
|
$133,200
$4.28 P/Share
|
|
Sep 07
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
3,111
+0.91%
|
$12,444
$4.0 P/Share
|
|
Sep 06
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
19,162
+5.41%
|
$57,486
$3.89 P/Share
|
|
Sep 02
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
400
+0.13%
|
$1,200
$3.74 P/Share
|
|
Sep 01
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
11,821
+3.61%
|
$35,463
$3.72 P/Share
|
|
Aug 31
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
24,975
+7.6%
|
$74,925
$3.75 P/Share
|
|
Aug 26
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
39,527
+12.42%
|
$118,581
$3.75 P/Share
|
|
Aug 24
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+2.05%
|
$15,000
$3.75 P/Share
|
|
Aug 23
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
40,000
+14.59%
|
$120,000
$3.5 P/Share
|
|
Aug 22
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
23,105
+10.63%
|
$69,315
$3.46 P/Share
|
|
Aug 19
2022
|
James Huang Director |
BUY
Open market or private purchase
|
Indirect |
171,116
+50.0%
|
$513,348
$3.27 P/Share
|
|
Jun 15
2022
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
50,000
+7.2%
|
$150,000
$3.18 P/Share
|
|
Jun 14
2022
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
2,096
+0.35%
|
$6,288
$3.06 P/Share
|
|
Jun 13
2022
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
36,058
+5.74%
|
$72,116
$2.97 P/Share
|
|
Nov 18
2021
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
200,000
+3.47%
|
$0
$0.98 P/Share
|
|
Nov 17
2021
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
200,000
+3.6%
|
$0
$0.99 P/Share
|
|
Aug 19
2021
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
180,000
+3.37%
|
$180,000
$1.26 P/Share
|
|
Aug 18
2021
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
300,000
+5.68%
|
$300,000
$1.29 P/Share
|
|
Mar 26
2021
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Indirect |
3,000,000
+50.0%
|
$6,000,000
$2.05 P/Share
|
|
Dec 22
2020
|
Wei Wu He Chairman and CEO |
SELL
Bona fide gift
|
Direct |
380,000
-7.5%
|
-
|
|
Dec 17
2020
|
Weihao Xu Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
4,000
+18.39%
|
$8,000
$2.64 P/Share
|
|
Dec 16
2020
|
Weihao Xu Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
2,000
+25.0%
|
$4,000
$2.44 P/Share
|
|
Nov 23
2020
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
100,000
+1.94%
|
$200,000
$2.18 P/Share
|
|
Nov 20
2020
|
Wei Wu He Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
127,471
+2.5%
|
$254,942
$2.12 P/Share
|